Extensive docking studies were carried out to investigate Epitalons interaction with various histone proteins, including H1/1, H1/3, H1/6, H2b, H3, and H4
Patients with GPX4 overexpression had a reduced 5-year OS of 73% compared to 97% in patients with normal GPX4 expression (HR 2.95
In 2006, Khavinson collaborated with lead author O.V
LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a Phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial
[PubMed] Abhijit Basu A, Dvorina N, Baldwin W, Mazumder B
In: Towards a Theory of Development